Till sidinnehåll
Kunskapsbank för cancervården Till cancercentrum.se


  1. Peeters S, Pages M, Gauchotte G, Miquel C, Cartalat-Carel S, Guillamo JS, et al. Interactions between glioma and pregnancy: insight from a 52-case multicenter series. Journal of neurosurgery. 2018;128(1):3-13.

  2. Ronning PA, Helseth E, Meling TR, Johannesen TB. The effect of pregnancy on survival in a low-grade glioma cohort. Journal of neurosurgery. 2016;125(2):393-400.

  3. Johansson ALV. Pregnancy and breast cancer : risk patterns, tumour characteristics and prognosis. Stockholm: Karolinska Institutet; 2016.

  4. Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013;31(20):2532-9.

  5. Cancer in pregnancy: International Network on Cancer, Infertility and Pregnancy(INCIP)

  6. National Toxicology P. NTP Monograph: Developmental Effects and Pregnancy Outcomes Associated With Cancer Chemotherapy Use During Pregnancy. NTP Monogr. 2013(2):i-214.

  7. Correa A, Cragan JD, Kucik JE, Alverson CJ, Gilboa SM, Balakrishnan R, et al. Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol. 2007;79(2):65-186.

  8. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Kirmeyer S, Mathews TJ, et al. Births: final data for 2009. Natl Vital Stat Rep. 2011;60(1):1-70.

  9. Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska MJ, Boere I, et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med. 2015;373(19):1824-34.

  10. Cardonick E, Usmani A, Ghaffar S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. American journal of clinical oncology. 2010;33(3):221-8.

  11. Cardonick EH, Gringlas MB, Hunter K, Greenspan J. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls. American journal of obstetrics and gynecology. 2015;212(5):658.e1-8.

  12. Kalter H, Warkany J. Congenital malformations (second of two parts). N Engl J Med. 1983;308(9):491-7.

  13. Kalter H, Warkany J. Medical progress. Congenital malformations: etiologic factors and their role in prevention (first of two parts). N Engl J Med. 1983;308(8):424-31.

  14. Ray JG, Bharatha A, Montanera WJ. Magnetic Resonance Imaging Exposure During Pregnancy-Reply. JAMA. 2016;316(21):2275-6.

  15. Gomes M, Matias A, Macedo F. Risks to the fetus from diagnostic imaging during pregnancy: review and proposal of a clinical protocol. Pediatr Radiol. 2015;45(13):1916-29.

  16. Nyman U, Bajc M, Eriksson H, Geijer H, Gunnarsson M, Hellgren M, et al. Diagnostik av lungemboli hos gravida. Skintigrafi eller datortomografi? Lakartidningen. 2010;107(15):989-94.

  17. Wan T, Skeith L, Karovitch A, Rodger M, Le Gal G. Guidance for the diagnosis of pulmonary embolism during pregnancy: Consensus and controversies. Thromb Res. 2017;157:23-8.

  18. Han SN, Lotgerink A, Gziri MM, Van Calsteren K, Hanssens M, Amant F. Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review. BMC medicine. 2012;10:86.

  19. Teasdale S, Morton A. Changes in biochemical tests in pregnancy and their clinical significance. Obstet Med. 2018;11(4):160-70.

  20. Serenius F, Ewald U, Farooqi A, Fellman V, Hafstrom M, Hellgren K, et al. Neurodevelopmental Outcomes Among Extremely Preterm Infants 6.5 Years After Active Perinatal Care in Sweden. JAMA pediatrics. 2016;170(10):954-63.

  21. Norman M, Hallberg B, Abrahamsson T, Bjorklund LJ, Domellof M, Farooqi A, et al. Association Between Year of Birth and 1-Year Survival Among Extremely Preterm Infants in Sweden During 2004-2007 and 2014-2016. Jama. 2019;321(12):1188-99.

  22. Hirvonen M, Ojala R, Korhonen P, Haataja P, Eriksson K, Gissler M, et al. Cerebral palsy among children born moderately and late preterm. Pediatrics. 2014;134(6):e1584-93.

  23. Vohr B. Long-term outcomes of moderately preterm, late preterm, and early term infants. Clinics in perinatology. 2013;40(4):739-51.

  24. Barthelmes L, Gateley CA. Tamoxifen and pregnancy. Breast. 2004;13(6):446-51.

  25. D'Addio F, Riella LV, Mfarrej BG, Chabtini L, Adams LT, Yeung M, et al. The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. Journal of immunology (Baltimore, Md : 1950). 2011;187(9):4530-41.

  26. Poulet FM, Wolf JJ, Herzyk DJ, DeGeorge JJ. An Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors. Birth defects research Part B, Developmental and reproductive toxicology. 2016;107(2):108-19.

  27. Burotto M, Gormaz JG, Samtani S, Valls N, Silva R, Rojas C, et al. Viable Pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy. Seminars in oncology. 2018;45(3):164-9.

  28. Han SN, Amant F, Cardonick EH, Loibl S, Peccatori FA, Gheysens O, et al. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy. Breast cancer research and treatment. 2018;168(2):551-7.

  29. Huybrechts KF, Hernandez-Diaz S, Straub L, Gray KJ, Zhu Y, Patorno E, et al. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring. Jama. 2018;320(23):2429-37.

  30. Avsluta amning. Stockholm: Rikshandboken i Barnhälsovård; 2018

Nästa kapitel
9 Arbetsgrupp